Results 1 to 1 of 1
Page 1 of 1
Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection.
55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA 29 Oct-2 Nov 2004 (Published in Hepatology)
Yuen, RMF; Kim, J; Averett, D; Wong, DKH; Kim, CR; Kerr, B; Ngai, WS; Yuen, JCH; Lai, CL2004263
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download